Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial (Q34469018)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial |
scientific article |
Statements
1 reference
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial (English)
1 reference
Feng-Cai Zhu
1 reference
Li-Hua Hou
1 reference
Jing-Xin Li
1 reference
Shi-Po Wu
1 reference
Pei Liu
1 reference
Gui-Rong Zhang
1 reference
Yue-Mei Hu
1 reference
Fan-Yue Meng
1 reference
Jun-Jie Xu
1 reference
Rong Tang
1 reference
Jin-Long Zhang
1 reference
Wen-Juan Wang
1 reference
Lei Duan
1 reference
Kai Chu
1 reference
Qi Liang
1 reference
Jia-Lei Hu
1 reference
Li Luo
1 reference
Tao Zhu
1 reference
Jun-Zhi Wang
1 reference
Wei Chen
1 reference
25 March 2015
1 reference
Identifiers
1 reference